Talk:Dipyaka: Difference between revisions
Dridhabala (talk | contribs) No edit summary |
Dridhabala (talk | contribs) No edit summary |
||
| Line 29: | Line 29: | ||
}} | }} | ||
'''[https://en.wikipedia.org/wiki/Trachyspermum_ammi Carum copticum Benth. & Hook.]''', commonly known as '''Dipyaka''' or '''Ajowan''', is an annual herbaceous plant widely cultivated for its aromatic fruits. In [[Ayurveda]], it is highly valued as a carminative, digestive stimulant, and Kapha-Vata pacifying medicine.<ref name="API"> | '''[https://en.wikipedia.org/wiki/Trachyspermum_ammi Carum copticum Benth. & Hook.]''', commonly known as '''Dipyaka''' or '''Ajowan''', is an annual herbaceous plant widely cultivated for its aromatic fruits. In [[Ayurveda]], it is highly valued as a carminative, digestive stimulant, and Kapha-Vata pacifying medicine.<ref name="API" /> ''Trachyspermum ammi'' (L.) Sprague is regarded as a synonym of ''Carum copticum''.<ref name="Boskabady2014" /> | ||
== English Name == | == English Name == | ||
| Line 50: | Line 50: | ||
* ''Brahmakusha'' | * ''Brahmakusha'' | ||
* ''Kaaravi'' | * ''Kaaravi'' | ||
* ''Lochamastaka''<ref name="Bhavaprakash" | * ''Lochamastaka''<ref name="Bhavaprakash" /> | ||
== Ayurvedic Pharmacological Properties == | == Ayurvedic Pharmacological Properties == | ||
| Line 128: | Line 128: | ||
== Major Phytoconstituents == | == Major Phytoconstituents == | ||
The pharmacological | The pharmacological activity of ''Trachyspermum ammi'' (''Carum copticum'') is mainly attributed to its essential oil. The oil composition varies with geographical origin: thymol is the main component of oil from south Indian plants (reported up to 97.9%), whereas carvacrol, γ-terpinene and ''p''-cymene are the main components of oil from other regions.<ref name="Boskabady2014" /> | ||
== Therapeutic Efficacy & Modern Scientific Research == | == Therapeutic Efficacy & Modern Scientific Research == | ||
Modern pharmacological | Modern pharmacological studies support several of the traditional uses of ''Trachyspermum ammi'' (''Carum copticum''): | ||
=== 1. Gastrointestinal and | === 1. Gastrointestinal and Antispasmodic Activity (''Deepana'' & ''Pachana'') === | ||
* '''Traditional Use:''' Used for | * '''Traditional Use:''' Used for ''Gulma'' (abdominal lump), ''Adhmana'' (abdominal distention), ''Aruchi'' (anorexia) and ''Sula'' (colic pain).<ref name="API" /> | ||
* ''' | * '''Scientific Evidence:''' The aqueous-methanolic seed extract inhibited K<sup>+</sup>-induced contractions in isolated rabbit jejunum and shifted Ca<sup>2+</sup> dose-response curves to the right, similar to verapamil, indicating a calcium channel blocking (antispasmodic) effect.<ref name="Gilani2005" /> | ||
=== 2. Antimicrobial | === 2. Antimicrobial Efficacy (''Krumiroga'') === | ||
* '''Traditional Use:''' Employed in | * '''Traditional Use:''' Employed in ''Krumi roga'' (worms / microbial infections).<ref name="API" /> | ||
* ''' | * '''Scientific Evidence:''' The essential oil of ''Carum copticum'' and its main compounds have been reported to have antibacterial and antifungal activity, assessed by MIC and MBC methods.<ref name="Kazemi2015" /> | ||
=== 3. Respiratory Support ('' | === 3. Respiratory Support (''Swasa'' & Bronchodilation) === | ||
* '''Traditional Use:''' Used in | * '''Traditional Use:''' Used in asthma and dyspnea (''Swasa'') and cough; the plant is described in traditional medicine as anti-asthmatic and anti-dyspneic.<ref name="Boskabady2014" /> | ||
* ''' | * '''Scientific Evidence:''' The seed extract inhibited carbachol- and K<sup>+</sup>-induced contractions in isolated guinea-pig trachea and shifted the carbachol and histamine dose-response curves to the right, suggesting a non-specific bronchodilator effect possibly mediated through calcium channel blockade.<ref name="Gilani2005" /> Bronchodilator effects of ''C. copticum'' have also been reviewed.<ref name="Boskabady2014" /> | ||
=== 4. Antioxidant and Anti-inflammatory Properties === | === 4. Antioxidant and Anti-inflammatory Properties === | ||
* ''' | * '''Scientific Evidence:''' The essential oil of ''Carum copticum'' showed antioxidant and anti-inflammatory properties in laboratory evaluation.<ref name="Kazemi2015" /> | ||
=== 5. Hepatoprotective and Antihypertensive Activity === | |||
* '''Scientific Evidence:''' In rats, pretreatment with the seed extract (500 mg/kg orally) prevented the rise in serum ALP and aminotransferases induced by paracetamol and carbon tetrachloride, and the extract caused a dose-dependent fall in arterial blood pressure in anaesthetized rats (3–100 mg/kg).<ref name="Gilani2005" /> | |||
== Summary of Therapeutic Profile == | == Summary of Therapeutic Profile == | ||
| Line 156: | Line 159: | ||
|- | |- | ||
| '''Gastrointestinal Colic / Flatulence''' | | '''Gastrointestinal Colic / Flatulence''' | ||
| | | Seed extract (calcium antagonist constituents) | ||
| | | Antispasmodic (calcium channel blockade)<ref name="Gilani2005" /> | ||
|- | |- | ||
| '''Microbial / Fungal Infections''' | | '''Microbial / Fungal Infections''' | ||
| Essential | | Essential oil | ||
| | | Antibacterial, antifungal<ref name="Kazemi2015" /> | ||
|- | |- | ||
| '''Respiratory Disorders / Asthma''' | | '''Respiratory Disorders / Asthma''' | ||
| | | Seed extract | ||
| Bronchodilation, | | Bronchodilation, tracheal smooth muscle relaxation<ref name="Gilani2005" /> | ||
|- | |- | ||
| '''Inflammation / Oxidative Stress''' | | '''Inflammation / Oxidative Stress''' | ||
| | | Essential oil | ||
| | | Antioxidant, anti-inflammatory<ref name="Kazemi2015" /> | ||
|} | |} | ||
== Safety, Toxicity, and Dosage == | == Safety, Toxicity, and Dosage == | ||
* '''Precautions:''' Due to the hot potency (''Ushna veerya'') and sharp qualities (''Tikshna guna''), it should be used cautiously in individuals with high Pitta aggravation or severe gastritis. | * '''Precautions:''' Due to the hot potency (''Ushna veerya'') and sharp qualities (''Tikshna guna''), it should be used cautiously in individuals with high Pitta aggravation or severe gastritis. This is a classical rationale rather than a clinical finding. | ||
* '''Standard Therapeutic Dosage:''' | * '''Standard Therapeutic Dosage:''' | ||
** ''Fruit Powder (Churna):'' 1 – 3 g daily.<ref name="API" /> | ** ''Fruit Powder (Churna):'' 1 – 3 g daily.<ref name="API" /> | ||
| Line 179: | Line 182: | ||
== References == | == References == | ||
{{Reflist|refs= | {{Reflist|refs= | ||
<ref name="API"> | <ref name="API">{{cite book |title=The Ayurvedic Pharmacopoeia of India |year=1986 |publisher=Department of Ayush, Ministry of Health and Family Welfare, Govt. of India |location=New Delhi |edition=Part I |volume=I |pages=02}}</ref> <!-- verify volume and page --> | ||
<ref name="Bhavaprakash">Shri | <ref name="Bhavaprakash">{{cite book |last=Bhavamishra |first=Shri |title=Bhavaprakash Nighantu |others=Edited by Padmashree Prof. Krushnachandra Chunekar |edition=Reprint |publisher=Chaukhambha Bharati Academy |year=2020 |pages=Haritakyadi Varga, verse 77}}</ref> | ||
<ref name=" | <ref name="Boskabady2014">{{cite journal |last1=Boskabady |first1=M. H. |last2=Alitaneh |first2=S. |last3=Alavinezhad |first3=A. |year=2014 |title=Carum copticum L.: a herbal medicine with various pharmacological effects |journal=BioMed Research International |volume=2014 |pages=569087 |doi=10.1155/2014/569087 |url=https://pmc.ncbi.nlm.nih.gov/articles/PMC4096002}}</ref> | ||
<ref name=" | <ref name="Gilani2005">{{cite journal |last1=Gilani |first1=A. H. |last2=Jabeen |first2=Q. |last3=Ghayur |first3=M. N. |last4=Janbaz |first4=K. H. |last5=Akhtar |first5=M. S. |year=2005 |title=Studies on the antihypertensive, antispasmodic, bronchodilator and hepatoprotective activities of the Carum copticum seed extract |journal=Journal of Ethnopharmacology |volume=98 |issue=1–2 |pages=127–135 |doi=10.1016/j.jep.2005.01.017 |pmid=15763373 |url=https://pubmed.ncbi.nlm.nih.gov/15763373/}}</ref> | ||
<ref name="Kazemi2015">{{cite journal |last=Kazemi |first=M. |year=2015 |title=Phenolic profile, antimicrobial and anti-inflammatory activity of Carum copticum L. essential oil |journal=Bulgarian Chemical Communications |volume=47 |issue=1 |pages=149–155 |url=https://hero.epa.gov/hero/index.cfm/reference/details/reference_id/3440018}}</ref> | |||
<ref name=" | |||
}} | }} | ||